2 hours ago
Johnson & Johnson (JNJ) Stock Reaches New Peak on Analyst Upgrade and Strong Drug Performance
Johnson & Johnson (JNJ) reached an all-time high of $251.76 following Guggenheim's upgrade to $270. Strong drug performance drives optimism ahead of Q2.
The post Johnson & Johnson (JNJ) Stock Reaches New Peak on Analyst Upgrade and Strong Drug Performance appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Securitize (SECZ) Set for NYSE Debut with $400M SPAC Merger Backing
- 1 hour ago
SMX (SMX) Stock: Drops as Tightening Recycling Regulations Spotlight Verificatio...
- 2 hours ago
OpenAI IPO Postponement to 2027 Sends Ripples Through Tech Markets
- 2 hours ago
Strategy (MSTR) Stock Plunges 35% in One Week as Bitcoin Crash Deepens
- 2 hours ago
Quantum Cyber (QUCY) Shares Jump 32% on SpaceX Investment Plans
